Evidence map›Paper›PMID 18606868›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2008

Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii.

Marcos Flores, Rafael Saavedra, Rocio Bautista, Rubi Viedma, Eda P Tenorio, Lin Leng, Yuriko Sánchez, Imelda Juárez, Anjali A Satoskar, Asha S Shenoy and 5 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. BthTX-II, an Asp49 PLAPharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Modeling the human placental barrier to understandFrontiers in cellular and infection microbiology · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Role of Host and Parasite MIF Cytokines duringTropical medicine and infectious disease · 2020
    Review
  15. Biogenic Silver Nanoparticles Can ControlFrontiers in microbiology · 2020
    Article
  16. Review
  17. Macrophage migration inhibitory factor regulates innate γδ T-cell responsesFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  18. IncreasedFrontiers in microbiology · 2019
    Article
  19. Cyclooxygenase (COX)-2 Inhibitors ReduceFrontiers in microbiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Marcos FloresUnidad de Biomedicina, FES-Iztacala, UNAM. Av. de los Barrios #1, Los Reyes Iztacala, 54090 Tlalnepantla, Mexico City, Mexico.
Rafael Saavedra
Rocio Bautista
Rubi Viedma
Eda P Tenorio
Lin Leng
Yuriko Sánchez
Imelda Juárez
Anjali A Satoskar
Asha S Shenoy
Luis I Terrazas
Richard Bucala
Joseph Barbi
Abhay R Satoskar
Miriam Rodriguez-Sosa
Universidad Nacional Autónoma de México · MXThe Ohio State University · USYale University · USKing Edward Memorial Hospital and Seth G.S. Medical College · INThe Ohio State University Wexner Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophage migration inhibitory factor (MIF) exerts either a protective or a deleterious role in the immune response to different pathogens. We analyzed herein the role of MIF in the host control of toxoplasmosis using MIF(-/-) mice backcrossed to either the BALB/c or the C57BL/6 genetic backgrounds. Both, wild-type (WT) BALB/c and MIF(-/-) BALB/c mice were susceptible to infection with highly virulent RH as well as moderately virulent ME49 strains of T. gondii. MIF(-/-) mice, however, showed greater liver damage and more brain cysts, produced less proinflammatory cytokines, and succumbed significantly faster than WT mice. Bone marrow-derived dendritic cells (BMDCs) from MIF(-/-) mice produced less interleukin-1beta, interleukin-12, and tumor necrosis factor-alpha than WT BMDCs after stimulation with soluble Toxoplasma antigen (STAg). Similar observations were made in CD11c(+) low-density cells isolated from the spleens of MIF(-/-) mice challenged with STAg. MIF(-/-) C57BL/6 mice succumbed to ME49 infection faster than their WT counterparts. C57BL/6 mice that succumbed to infection with the ME49 strain produced less MIF than resistant BALB/c mice similarly infected. Interestingly, an analysis of brains from patients with cerebral toxoplasmosis showed low levels of MIF expression. Together, these findings demonstrate that MIF plays a critical role in mediating host resistance against T. gondii.

Indexed as

Genetic Predisposition to DiseaseHost-Parasite InteractionsImmunity, InnateAnimalsBrainCytokinesDendritic CellsEncephalitisHepatitisHumansIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMiceMice, Mutant StrainsNitric AcidToll-Like Receptor 2CytokinesIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMif protein, mouseNitric AcidTlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID18606868
PMCPMC2537436
OpenAlexW2135562131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.